Our portfolio
Our portfolio of value-added generic medicines primarily addresses problems of patients suffering from diseases in the gastrointestinal and hepatobiliary tracts, but our product range extends to patient care in cardiology, psychiatry, urology and other conditions. By maintaining a continuous focus on identifying novel treatments and indications, we are committed to bringing innovative and affordable medicines to patients.